Stock Events

Stock Events

Acusphere 

$0
3
+$0+0% Tuesday 21:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

7NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACUS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap279.67B
Novartis is involved in the development of healthcare solutions including drug delivery technologies similar to Acusphere's, making them direct competitors in the pharmaceuticals market.
Pfizer
PFE
Mkt Cap149.77B
Pfizer develops advanced drug delivery systems and pharmaceuticals that compete with Acusphere's product offerings.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division, competes in the same space as Acusphere, particularly in the innovation of drug delivery technologies.
Merck
MRK
Mkt Cap277.02B
Merck produces drugs and technologies that directly compete with Acusphere's specialty in pharmaceutical formulations.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories offers medical devices and pharmaceuticals that overlap with Acusphere's market, particularly in targeted drug delivery systems.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company competes with Acusphere in the pharmaceutical sector, focusing on drug delivery and formulation.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb operates in the same pharmaceutical and biotechnology areas as Acusphere, making them a competitor in drug delivery innovations.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline focuses on developing drugs and formulations that compete with Acusphere's technologies in the pharmaceutical market.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with Acusphere in the global pharmaceutical market, particularly in areas involving complex drug delivery systems.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca is involved in the development and commercialization of pharmaceutical products that compete with Acusphere's drug delivery technologies.

About

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
Show more...
CEO
Dr. William I. Ramage D.Phil
Employees
50
Country
United States
ISIN
US00511R8549

Listings

OTC Link
US
ACUS

0 Comments

Share your thoughts

FAQ

What is Acusphere stock price today?▼
The current price of ACUS is $0 USD — it has increased by +0% in the past 24 hours. Watch Acusphere stock price performance more closely on the chart.
What is Acusphere stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acusphere stocks are traded under the ticker ACUS.
What were Acusphere earnings last quarter?▼
ACUS earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Acusphere have?▼
As of May 06, 2026, the company has 50 employees.
In which sector is Acusphere located?▼
Acusphere operates in the Health & Wellness sector.
When did Acusphere complete a stock split?▼
Acusphere has not had any recent stock splits.
Where is Acusphere headquartered?▼
Acusphere is headquartered in Watertown, United States.